These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 12755095)
1. IRBs and monitoring the safety of clinical trials. Maloney DM Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095 [No Abstract] [Full Text] [Related]
2. IRBs, data sharing, and privacy of human subjects. Maloney DM Hum Res Rep; 2002 Apr; 17(4):3. PubMed ID: 12374179 [No Abstract] [Full Text] [Related]
3. Safety boards must report their conclusions to IRBs. Maloney DM Hum Res Rep; 1999 Oct; 14(10):3. PubMed ID: 11658061 [No Abstract] [Full Text] [Related]
4. The IRB is not a data and safety monitoring board. Bankert E; Amdur R IRB; 2000; 22(6):9-11. PubMed ID: 11883486 [No Abstract] [Full Text] [Related]
5. Continued concern: human subject protection, the institutional review board, and continuing review. Hoffman S Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912 [No Abstract] [Full Text] [Related]
6. Institutional review boards (IRBs) and working with adverse event reports. Maloney DM Hum Res Rep; 2005 Dec; 20(12):1-3. PubMed ID: 16607708 [No Abstract] [Full Text] [Related]
7. How institutional review boards (IRBs) can handle adverse event reports. Maloney DM Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305 [No Abstract] [Full Text] [Related]
8. Regulating clinical research: informed consent, privacy, and IRBs. Hoffman S Cap Univ Law Rev; 2003; 31(1):71-91. PubMed ID: 15295833 [No Abstract] [Full Text] [Related]
12. Reporting problems in human research and resultant investigations by IRBs. Maloney DM Hum Res Rep; 2002 Aug; 17(8):6-7. PubMed ID: 12731495 [No Abstract] [Full Text] [Related]
13. IRBs and financial conflict of interest. Maloney DM Hum Res Rep; 2000 Nov; 15(11):3. PubMed ID: 11767804 [No Abstract] [Full Text] [Related]
14. A central institutional review board for multi-institutional trials. Christian MC; Goldberg JL; Killen J; Abrams JS; McCabe MS; Mauer JK; Wittes RE N Engl J Med; 2002 May; 346(18):1405-8. PubMed ID: 11986418 [No Abstract] [Full Text] [Related]
15. Current issues in clinical research and the development of new pharmaceuticals. Goldhammer A Account Res; 2001; 8(4):283-91. PubMed ID: 12481798 [TBL] [Abstract][Full Text] [Related]
16. Research involving children: regulations, review boards and reform. Gandhi R J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026 [No Abstract] [Full Text] [Related]
17. IRB reform. Slater EE N Engl J Med; 2002 May; 346(18):1402-4. PubMed ID: 11986417 [No Abstract] [Full Text] [Related]
18. Restoring public trust in gene therapy. Kennedy EM J Biolaw Bus; 2001; 4(3):3-4. PubMed ID: 12962103 [No Abstract] [Full Text] [Related]
19. Central IRBs: why are some institutions reluctant to sign on? McNeil C J Natl Cancer Inst; 2005 Jul; 97(13):953-5. PubMed ID: 15998943 [No Abstract] [Full Text] [Related]
20. Numerous violations of federal informed consent requirements. Maloney DM Hum Res Rep; 2004 Jan; 19(1):1-3. PubMed ID: 14997901 [No Abstract] [Full Text] [Related] [Next] [New Search]